Eric Metzger

Breisacher Str. 66
Freiburg, BW 79106, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Development of High-Affinity CHD1 Chromodomain Inhibitors.

Development of High-Affinity CHD1 Chromodomain Inhibitors.

Journal: Journal of medicinal chemistry

Published: May 05, 2026

Structure-Guided Design of a KMT9 Inhibitor Prodrug with Cellular Activity.

Structure-Guided Design of a KMT9 Inhibitor Prodrug with Cellular Activity.

Journal: Journal of medicinal chemistry

Published: June 17, 2025

Lysine-specific demethylase 1 regulates hematopoietic stem cell expansion and myeloid cell differentiation.

Lysine-specific demethylase 1 regulates hematopoietic stem cell expansion and myeloid cell differentiation.

Journal: Cell death & disease

Published: June 12, 2025

KDM4A promotes NEPC progression through regulation of MYC expression.

KDM4A promotes NEPC progression through regulation of MYC expression.

Journal: Cancer letters

Published: June 10, 2025

Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML.

Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML.

Journal: Blood

Published: April 24, 2025

Sensitization of Non-M3 Acute Myeloid Leukemia Blasts to All-Trans Retinoic Acid by the LSD1 Inhibitor Tranylcypromine: TRANSATRA Phase I Study.

Sensitization of Non-M3 Acute Myeloid Leukemia Blasts to All-Trans Retinoic Acid by the LSD1 Inhibitor Tranylcypromine: TRANSATRA Phase I Study.

Journal: European journal of haematology

Published: February 17, 2025

Overexpression of KMT9α is associated with poor outcome in cholangiocarcinoma patients.

Overexpression of KMT9α is associated with poor outcome in cholangiocarcinoma patients.

Journal: Journal of cancer research and clinical oncology

Published: February 12, 2025

Modeling a mesenchymal cell state by bioprinting for the molecular analysis of dormancy in melanoma.

Modeling a mesenchymal cell state by bioprinting for the molecular analysis of dormancy in melanoma.

Journal: Materials today. Bio

Published: January 16, 2025

Lysine-specific histone demethylase 1a regulates nephron development and long-term transcriptional programming.

Lysine-specific histone demethylase 1a regulates nephron development and long-term transcriptional programming.

Journal: JCI insight

Published: December 13, 2024

Structure-Activity Studies of 1,2,4-Oxadiazoles for the Inhibition of the NAD+-Dependent Lysine Deacylase Sirtuin 2.

Structure-Activity Studies of 1,2,4-Oxadiazoles for the Inhibition of the NAD+-Dependent Lysine Deacylase Sirtuin 2.

Journal: Journal of medicinal chemistry

Published: June 07, 2024

Soft drug inhibitors for the epigenetic targets lysine-specific demethylase 1 and histone deacetylases.

Soft drug inhibitors for the epigenetic targets lysine-specific demethylase 1 and histone deacetylases.

Journal: Archiv der Pharmazie

Published: June 04, 2024

Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer.

Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer.

Journal: Cancers

Published: February 13, 2024

Showing 1-12 of 46

Last Updated: 09/26/2026